Clinical Trials in Beijing, Chaoyang
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Metastatic Hormone Sensitive Prostate Cancer
Novartis Pharmaceuticals150 enrolled57 locationsNCT06991556
Recruiting
Phase 2
Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor
Malignancy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences400 enrolled1 locationNCT05761366